Clopidogrel protects endothelium by hindering TNF α -Induced VCAM-1 Expression through CaMKK β /AMPK/Nrf2 Pathway

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Yang, Huabing ^a,b   Zhao, Pengjun ^c   Tian, Shiliu ^d  

^a HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF SPORT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENYLATE KINASE; ANTIINFLAMMATORY AGENT; CLOPIDOGREL; GLUTATHIONE; HEME OXYGENASE 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTIOXIDANT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CAMKK2 PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NFE2L2 PROTEIN, HUMAN; TICLOPIDINE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; AORTA ENDOTHELIUM; ARTICLE; CELL ADHESION; CELL FRACTIONATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HL 60 CELL LINE; HUMAN; HUMAN CELL; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HL-60 CELL LINE; LEUKOCYTE; METABOLISM; TIME FACTOR;

AMP-ACTIVATED PROTEIN KINASES; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL ADHESION; ENDOTHELIAL CELLS; GLUTATHIONE; HEME OXYGENASE-1; HL-60 CELLS; HUMANS; LEUKOCYTES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TICLOPIDINE; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84956876330     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/9128050     Document Type: Article

References (55)

1. Y. S. Kim, Y. Ahn, M. H. Hong et al., "Curcumin attenuates inflammatory responses of TNF-α-stimulated human endothelial cells, " Journal of Cardiovascular Pharmacology, vol. 50, no. 1, pp. 41-49, 2007.
2. Y. Shi and P. M. Vanhoutte, "Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes, " Journal of diabetes, vol. 1, no. 3, pp. 151-162, 2009.
3. S. Mitra and E. Abraham, "Participation of superoxide in neutrophil activation and cytokine production, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1762, no. 8, pp. 732-741, 2006.
4. M. A. Gimbrone Jr., T. Nagel, and J. N. Topper, "Biomechanical activation: an emerging paradigm in endothelial adhesion biology, " Journal of Clinical Investigation, vol. 100, no. 11, supplement, pp. S61-S65, 1997.
5. N. Morisaki, K. Takahashi, R. Shiina et al., "Platelet-derived growthfactor isapotent stimulator of expressionof intercellular adhesion molecule-1 in human arterial smooth muscle cells, " Biochemical and Biophysical ResearchCommunications, vol. 200, no. 1, pp. 612-618, 1994.
6. M. A. Read, A. S. Neish, F. W. Luscinskas, V. J. Palombella, T. Maniatis, and T. Collins, "The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression, " Immunity, vol. 2, no. 5, pp. 493-506, 1995.
7. R. Rothlein, M. Czajkowski, M. M. O'Neill, S. D. Marlin, E. Mainolfi, and V. J. Merluzzi, "Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by proinflammatory cytokines: regulation by pharmacologic agents and neutralizing antibodies, " Journal of Immunology, vol. 141, no. 5, pp. 1665-1669, 1988.
8. M. I. Cybulsky and M. A. Gimbrone Jr., "Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis, " Science, vol. 251, no. 4995, pp. 788-791, 1991.
9. A. M. K. Choi and J. Alam, "Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury, " American Journal of Respiratory Cell and Molecular Biology, vol. 15, no. 1, pp. 9-19, 1996.
10. M. D. Maines and A. Kappas, "Cobalt induction of hepatic heme oxygenase, with evidence that cytochrome P-450 is not essential for this enzyme activity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 11, pp. 4293-4297, 1974.
11. M. Maines, "Carbon monoxide and nitric oxide homology: differentialmodulationof heme oxygenases inbrainanddetection of protein and activity, " Methods in Enzymology, vol. 268, pp. 473-488, 1996.
12. R. Stocker, Y. Yamamoto, A. F. McDonagh, A. N. Glazer, and B. N. Ames, "Bilirubin is an antioxidant of possible physiological importance, " Science, vol. 235, no. 4792, pp. 1043-1046, 1987.
13. R. Motterlini, A. Gonzales, R. Foresti, J. E. Clark, C. J. Green, and R. M. Winslow, "Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo, " Circulation Research, vol. 83, no. 5, pp. 568-577, 1998.
14. I. A. Sammut, R. Foresti, J. E. Clark et al., "Carbonmonoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1, " British Journal of Pharmacology, vol. 125, no. 7, pp. 1437-1444, 1998.
15. X.-M. Liu, K. J. Peyton, A. R. Shebib, H. Wang, R. J. Korthuis, and W. Durante, "Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 1, pp. H84-H93, 2011.
16. C.-S. Huang, C.-K. Lii, A.-H. Lin et al., "Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes, " Archives of Toxicology, vol. 87, no. 1, pp. 167-178, 2013.
17. A.-L. Yu, C.-Y. Lu, T.-S. Wang et al., "Induction of heme oxygenase 1 and inhibition of tumor necrosis factor alpha-induced intercellular adhesion molecule expression by andrographolide in EA. hy926 cells, " Journal of Agricultural and Food Chemistry, vol. 58, no. 13, pp. 7641-7648, 2010.
18. S. Levy, A. K. Jaiswal, and H. J. Forman, "The role of c-Jun phosphorylation in EpRE activation of phase II genes, " Free Radical Biology & Medicine, vol. 47, no. 8, pp. 1172-1179, 2009.
19. N. R. Hadi, B. I. Mohammad, I. M. Ajeena, and H. H. Sahib, "Antiatherosclerotic potential of clopidogrel: antioxidant and anti-inflammatory approaches, " BioMed Research International, vol. 2013, Article ID790263, 10 pages, 2013.
20. J. Graff, S. Harder, O. Wahl, E.-H. Scheuermann, and J. Gossmann, "Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers, " Clinical Pharmacology and Therapeutics, vol. 78, no. 5, pp. 468-476, 2005.
21. U. Klinkhardt, R. Bauersachs, J. Adams, J. Graff, E. Lindhoff-Last, and S. Harder, "Clopidogrel but not aspirin reduces Pselectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease, " Clinical Pharmacology andTherapeutics, vol. 73, no. 3, pp. 232-241, 2003.
22. A. Millius and O. D. Weiner, "Chemotaxis in neutrophil-like HL-60 cells, "Methods inMolecular Biology, vol. 571, pp. 167-177, 2009.
23. G. A. Visner, F. Lu, H. Zhou, J. Liu, K. Kazemfar, and A. Agarwal, "Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin, " Circulation, vol. 107, no. 6, pp. 911-916, 2003.
24. S.-C. Tang, M.-F. Wu, R.-H. Wong et al., "Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer, " Cancer, vol. 117, no. 14, pp. 3209-3221, 2011.
25. Y.-C. Yang, C.-K. Lii, Y.-L. Wei et al., "Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-B pathways, " The Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 204-212, 2013.
26. C.-Y. Lu, Y.-C. Yang, C.-C. Li, K.-L. Liu, C.-K. Lii, and H.-W. Chen, "Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells, " Biochemical Pharmacology, vol. 91, no. 1, pp. 40-50, 2014.
27. H.-W. Chen, A.-H. Lin, H.-C. Chu et al., "Inhibition of TNFalpha-induced inflammation by andrographolide via downregulation of the PI3K/Akt signaling pathway, " Journal of Natural Products, vol. 74, no. 11, pp. 2408-2413, 2011.
28. J. Kang, I. Choi, M. Han et al., "The cytoprotective effect of petalonia binghamiae methanol extract against oxidative stress in C2C12 myoblasts: mediation by upregulation of heme oxygenase-1 and nuclear factor-erythroid 2 related factor 2, " Marine Drugs, vol. 13, no. 5, pp. 2666-2679, 2015.
29. G. Scapagnini, D. A. Butterfield, C. Colombrita, R. Sultana, A. Pascale, and V. Calabrese, "Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress, " Antioxidants and Redox Signaling, vol. 6, no. 5, pp. 811-818, 2004.
30. S. L. Colombo and S. Moncada, "AMPKalpha1 regulates the antioxidant status of vascular endothelial cells, "The Biochemical Journal, vol. 421, no. 2, pp. 163-169, 2009.
31. B. Ziemianin, R. Olszanecki, W. Uracz, E. Marcinkiewicz, and R. J. Gryglewski, "Thienopyridines: effects on cultured endothelial cells, " Journal of Physiology and Pharmacology, vol. 50, no. 4, pp. 597-604, 1999.
32. D. Vishnevetsky, V. A. Kiyanista, and P. J. Gandhi, "CD40ligand: a novel in the fight against cardiovascular disease, " The Annals of Pharmacotherapy, vol. 38, no. 9, pp. 1500-1508, 2004.
33. W. W. Hancock, R. Buelow, M. H. Sayegh, and L. A. Turka, "Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes, " Nature Medicine, vol. 4, no. 12, pp. 1392-1396, 1998.
34. J. A. McClung, A. L. Kruger, A. Ferraris et al., "Usefulness of clopidogrel to protect against diabetes-induced vascular damage, "The American Journal of Cardiology, vol. 105, no. 7, pp. 1014-1018, 2010.
35. W. J. Beil, P. F. Weller, M. A. Peppercorn, S. J. Galli, and A. M. Dvorak, "Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohns disease, " Journal of Leukocyte Biology, vol. 58, no. 3, pp. 284-298, 1995.
36. R. Brezina, S. Schramek, and J. Kazar, "Selection of chlortetracycline resistant strain of Coxiella burnetii, " Acta Virologica, vol. 19, no. 6, article 496, 1975.
37. H. Arimura, "Correlation between molecular size and interferon-inducing activity of poly I:C, " Acta Virologica, vol. 19, no. 6, pp. 457-466, 1975.
38. R. F. Wachter, G. P. Briggs, and C. E. Pedersen Jr., "Precipitation of phase I antigen of Coxiella burnetii by sodium sulfite, " Acta Virologica, vol. 19, no. 6, p. 500, 1975.
39. V. F. Ignatovich, "Enhancement of the antigenic activity and virulence of the vaccine strain E of Rickettsia prow azeki by passages in cell culture, " Acta Virologica, vol. 19, no. 6, pp. 481-485, 1975.
40. J. B. Share, "Review of drug treatment for Downs syndrome persons, " American Journal of Mental Deficiency, vol. 80, no. 4, pp. 388-393, 1976.
41. V. V. Pogodina, ElizavetaNilolaevna Levkovich-75th birthday, " Acta Virologica, vol. 19 6 article 509 1975
42. R. D. Bland, T. L. Clarke, and L. B. Harden, "Rapid infusion of sodium bicarbonate and albumin into high-risk premature infants soon after birth: a controlled, prospective trial, " American Journal of Obstetrics & Gynecology, vol. 124, no. 3, pp. 263-267, 1976.
43. N. G. Abraham and A. Kappas, "Pharmacological and clinical aspects of heme oxygenase, " Pharmacological Reviews, vol. 60, no. 1, pp. 79-127, 2008.
44. K. Ishikawa, M. Navab, and A. J. Lusis, "Vasculitis, atherosclerosis, and altered HDL composition in heme-oxygenase-1-knockout mice, " International Journal ofHypertension, vol. 2012, Article ID 948203, 6 pages, 2012.
45. T. Li, H. Tian, Y. Zhao et al., "Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis, " European Journal of Pharmacology, vol. 672, no. 1-3, pp. 143-152, 2011.
46. J.-Y. Tsai, K.-H. Su, S.-K. Shyue et al., "EGb761 ameliorates the formationof foamcellsby regulating the expressionof SR-Aand ABCA1: role of haem oxygenase-1, " Cardiovascular Research, vol. 88, no. 3, pp. 415-423, 2010.
47. K. Pyorala, M. Laakso, and M. Uusitupa, "Diabetes and atherosclerosis: an epidemiologic view, " Diabetes/Metabolism Reviews, vol. 3, no. 2, pp. 463-524, 1987.
48. J. Fan and T. Watanabe, "Inflammatory reactions in the pathogenesis of atherosclerosis, " Journal of Atherosclerosis and Thrombosis, vol. 10, no. 2, pp. 63-71, 2003.
49. R. R. S. Packard and P. Libby, "Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction, " Clinical Chemistry, vol. 54, no. 1, pp. 24-38, 2008.
50. H. Li, M. I. Cybulsky, M. A. Gimbrone Jr., and P. Libby, "An atherogenic diet rapidly induces VCAM-1, a cytokineregulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 13, no. 2, pp. 197-204, 1993.
51. P. Libby, "Inflammation in atherosclerosis, " Nature, vol. 420, no. 6917, pp. 868-874, 2002.
52. C. Chen and A. N. Kong, "Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects, " Trends in Pharmacological Sciences, vol. 26, no. 6, pp. 318-326, 2005.
53. G. Shen, W.-S. Jeong, R. Hu, and A.-N. T. Kong, "Regulation of Nrf2, NF-B, and AP-1 signaling pathways by chemopreventive agents, " Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1648-1663, 2005.
54. K. Itoh, N. Wakabayashi, Y. Katoh et al., "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, " Genes &Development, vol. 13, no. 1, pp. 76-86, 1999.
55. G. Costa, V. Francisco, M. C. Lopes, M. T. Cruz, and M. T. Batista, "Intracellular signaling pathways modulated by phenolic compounds: application for new anti-inflammatory drugs discovery, " Current Medicinal Chemistry, vol. 19, no. 18, pp. 2876-2900, 2012.